---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-027988"
form_type: "8-K"
ticker: "TERN"
cik: "0001831363"
company_name: "Terns Pharmaceuticals, Inc."
filed_at: "2023-06-14T23:59:59+00:00"
generated_at: "2026-06-14T01:32:09.515673+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Terns Pharmaceuticals stockholders elect three Class II directors, ratify E&Y as auditor

## Summary
- David Fellows, Jill Quigley, and Radhika Tripuraneni elected as Class II directors with 39.5M, 40.1M, and 45.9M votes for, respectively.
- Ratification of Ernst & Young as independent auditor for FY 2023 passed with 53.4M votes for, 1,549 against, 331 abstentions.
- All director nominees received more votes for than withheld; broker non-votes of 7.4M shares on director election.
- No other business items were presented; all proposals were approved as described in the April 28 proxy statement.

## SEC filing metadata
- accession: 0000950170-23-027988
- form_type: 8-K
- ticker: TERN
- cik: 0001831363
- company_name: Terns Pharmaceuticals, Inc.
- filed_at: 2023-06-14T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831363/000095017023027988/0000950170-23-027988-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831363/000095017023027988/tern-20230612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-027988
- JSON: https://secwatch.observer/filing/0000950170-23-027988.json
- Plain text: https://secwatch.observer/filing/0000950170-23-027988.txt

## Key facts
- Shareholder Votes
  Terns Pharmaceuticals, Inc. shareholders approved Ratification of selection of Ernst & Young LLP as independent registered public accounting firm for fiscal year 2023 at the 2023-06-12 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-12
  source text: Proposal 2 . The ratification of the selection, by the audit committee of the board of directors, of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2023: Votes For Votes Against Abstentions 53,416,393 1,549 331
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831363/000095017023027988/0000950170-23-027988-index.htm
- Shareholder Votes
  Terns Pharmaceuticals, Inc. shareholders approved Election of three Class II directors to hold office until the 2026 annual meeting at the 2023-06-12 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-12
  source text: Proposal 1 . The election of three Class II directors to hold office until the 2026 annual meeting of stockholders or until their respective successor is elected: Nominee Votes For Votes Withheld Broker Non-Votes David Fellows 39,504,333 6,471,007 7,442,933 Jill Quigley, Esq. 40,103,150 5,872,190 7,442,933 Radhika Tripuraneni , M.D., M.P.H. 45,971,176 4,164 7,442,933
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831363/000095017023027988/0000950170-23-027988-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.